Chemed (CHE) net assets (shareholders' equity)

Net assets · fiscal 2025
$979.41M

Chemed (CHE) had net assets of $979.41M at the end of fiscal 2025 (December 31, 2025). That is 12.5% lower than the $1.12B of fiscal 2024. Figures as of 19 Nov 2026, 00:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$979.41M
Change on fiscal 2024
−12.5%
Growth, 5 years
+1.7% a year
Growth, 10 years
+6.7% a year
Highest on record
$1.12Bfiscal 2024
Lowest on record
$396.83Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Chemed net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 1.7% a year; over ten years the rate was 6.7% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.12B in fiscal 2024 and the lowest $396.83M in fiscal 2008.

History · 18 fiscal years

Net assets by fiscal year

Chemed net assets (shareholders' equity), year by year

Chemed (CHE) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$979.41M 12.5% down
2024$1.12B 1.0% up
2023$1.11B 38.7% up
2022$798.72M 28.1% up
2021$623.27M 30.8% down
2020$901.20M 24.0% up
2019$726.61M 22.9% up
2018$591.33M 9.4% up
2017$540.35M 3.1% up
2016$524.10M 2.1% up
2015$513.25M 13.7% up
2014$451.36M 0.5% up
2013$448.89M 1.0% down
2012$453.29M 9.6% up
2011$413.68M 10.5% down
2010$462.05M 3.2% down
2009$477.16M 20.2% up
2008$396.83M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Chemed and comparable companies
CompanyNet assetsFiscal year
Immunovant IMVT$852.59M2026
Axsome Therapeutics AXSM$88.30M2025
Chemed CHE$979.41M2025
Oruka Therapeutics ORKA$471.93M2025
Arrowhead Pharmaceuticals ARWR$50.31M2026
MSA Safety MSA$1.37B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CHE

Chemed, figure by figure

Chemed (CHE) overview: price, valuation and scorecardAll health care companies by market value

Chemed net assets (shareholders' equity): questions and answers

What are Chemed's net assets?

Chemed (CHE) had net assets of $979.41M at the end of fiscal 2025 (December 31, 2025). That is 12.5% lower than the $1.12B of fiscal 2024.

What is the growth rate of Chemed's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 1.7% a year; over ten years the rate was 6.7% a year.

What are the highest and lowest net assets figures on record for Chemed?

Across the 18 fiscal years on record (2008–2025), the highest was $1.12B in fiscal 2024 and the lowest $396.83M in fiscal 2008.

How is Chemed's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Chemed it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Chemed (CHE) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/CHE/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.